Tweet from EricTopol at February 23, 2022 at 07:50AM
The mixed findings as to whether the Sotrovimab monoclonal antibody works against the BA.2 variant
https://t.co/T0sIuVjCCl but it appears that Bebtelovimab does
@nature by @FKreier https://t.co/d762qFqnzu— Eric Topol (@EricTopol)
Feb 23, 2022
from http://twitter.com/EricTopol